Mudit Mishra Selected Research

HDL Lipoproteins

10/2022	Impact of High-Density Lipoproteins on Sepsis.
12/2020	High-Density Lipoprotein-Targeted Therapies for Heart Failure.
9/2017	Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mudit Mishra Research Topics

Disease

9	Heart Failure 03/2023 - 09/2017
8	Fibrosis (Cirrhosis) 07/2022 - 01/2017
5	Cardiomegaly (Heart Hypertrophy) 07/2022 - 09/2017
4	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2017
3	Reperfusion Injury 01/2023 - 01/2020
2	Heart Diseases (Heart Disease) 01/2023 - 01/2018
2	Microvascular Rarefaction 07/2022 - 01/2020
2	Hypertrophy 07/2022 - 01/2020
2	Diabetic Cardiomyopathies 01/2022 - 03/2019
2	Myocardial Infarction 11/2021 - 01/2020
2	Hypercholesterolemia 05/2019 - 01/2019
2	Pulmonary Edema 03/2019 - 01/2017
1	Sepsis (Septicemia) 10/2022
1	Atherosclerotic Plaque (Atheroma) 07/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022
1	Hyperglycemia 01/2022
1	Infarction (Infarctions) 11/2021
1	Cardiac Edema 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Primary Graft Dysfunction 01/2020
1	Type 2 Diabetes Mellitus (MODY) 05/2019
1	Hypotension (Low Blood Pressure) 01/2018
1	Obesity 01/2017
1	Insulin Resistance 01/2017
1	Weight Gain 01/2017

Drug/Important Bio-Agent (IBA)

4	MDCO-216IBA 01/2020 - 10/2018
3	HDL CholesterolIBA 10/2022 - 09/2017
3	EnzymesIBA 10/2022 - 11/2021
3	HDL LipoproteinsIBA 10/2022 - 09/2017
3	CholesterolIBA 05/2019 - 11/2017
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2022 - 09/2017
2	AntioxidantsIBA 01/2022 - 11/2021
2	LDL Receptors (LDL Receptor)IBA 05/2019 - 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 03/2023
1	SodiumIBA 03/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2023
1	Cholesterol Ester Transfer ProteinsIBA 10/2022
1	Phospholipid Transfer ProteinsIBA 10/2022
1	Lipoproteins (Lipoprotein)IBA 07/2022
1	Apolipoproteins E (ApoE)IBA 07/2022
1	ApolipoproteinsIBA 07/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	ThioredoxinsIBA 11/2021
1	Heme Oxygenase-1IBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Apolipoproteins AIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	CytokinesIBA 01/2020
1	apolipoprotein A-I MilanoIBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Sucrose (Saccharose)IBA 05/2019
1	SugarsIBA 03/2019
1	BuffersIBA 11/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Coconut OilIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2020
1	Immunomodulation 01/2023
1	Heart Transplantation (Grafting, Heart) 01/2020